General MedicationsINJECTIONGeneric

TROBICIN

SPECTINOMYCIN HYDROCHLORIDE

Standard Dose

EQ 2GM BASE/VIAL

Max Dose

Refer to approved labeling

Primary Use

Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview TROBICIN is listed in Drugs@FDA under application 050347 (NDA).

Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.

Structured Monograph

Clinical summary

Approval overview TROBICIN is listed in Drugs@FDA under application 050347 (NDA). Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. Review priority: STANDARD Marketing status: Discontinued Active ingredient SPECTINOMYCIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Sponsor PFIZER Submission history Latest submission status date: 2012-08-15 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.